Pharmafile Logo

Webcast: How to improve the patient journey through an effective engagement and activation strategy

Watch part two in a series, Evolving Patient Journeys, in which experts from across Inizio explore why, despite best intentions, patient engagement solutions can fall short of expectations.

The global pandemic has caused the health and life science industry to change more in the last three years than it has in the last three decades. The accelerated adoption of digital in all areas of the healthcare landscape has dramatically altered the patient journey.  Now more than ever, healthcare stakeholders need support from pharma to help deliver optimal care to patients.  But are current engagement strategies working as well as they could be?

Watch part two in a series, Evolving Patient Journeys, in which experts from across Inizio explore why, despite best intentions, patient engagement solutions can fall short of expectations.

Using a typical product profile scenario in an area of high unmet need, they will demonstrate how pharmaceutical manufacturers can improve the patient journey through a combination of insight generation, engagement strategy and activation.

Research Partnership Director, Liza Pliss was joined by Nareda Mills, Global President, Patient Solutions at Ashfield Engage and Edward Gajewski, Principal at Nuvera Life Science Consulting.

They will share best-practice and practical insight on how to develop suitable research programs, strategies and initiatives that successfully support stakeholders throughout the journey, improve brand engagement and ultimately improve patient outcomes.

What you will learn:

  • How to gather the right insights for early commercialization and to guide the design of clinical trials
  • How to gain a foundational patient understanding in a new disease area or for a new asset in an area of unmet need
  • How to get a deeper understanding of the changing emotional needs of patients and their new digital behaviours in areas of chronic illness
  • How to deploy engagement tactics throughout the journey and product lifecycle

Watch here

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Rare diseases and orphan drugs: Our experience and expertise

We have designed a complimentary infographic outlining the market opportunity as well as our experience and expertise in the growing area of rare diseases and orphan drugs, which includes links to...

Conducting research for publication video

APAC Director Pei Li Teh explains how real world insights provide an opportunity for brands to find, demonstrate and communicate their real value to patients, healthcare and society.Watch the video: https://bit.ly/2OcOWNu

Conference research case study

How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event

Portfolio analysis: Using market research to master communications across a therapeutic category

Many of us are familiar with billiard games, where two players compete to be the first to pocket all the balls on the table in a particular order.  We recently...

EphMRA round up 2018

EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.

Patients’willingness to pay

Considerations when developing an appropriate pricing strategy in self-pay markets

Research Partnership launches new patient Living with Diabetes (LATAM) 2018 report

Living with Diabetes is a study conducted amongst approximately 200 Type 2 (T2D) diabetes patients in Brazil and Mexico. The report will consist of quantitative 30-minute online and qualitative telephone...

Scratching the surface: unmet needs in psoriasis

Director Mariel Metcalfe shares some key findings from a recent Living with psoriasis study conducted in Europe, which is now available to purchase.Psoriasis is a skin condition but its impact...

Shift to preventative healthcare – Opportunities for screening, diagnostics and vaccination

Across emerging markets we are seeing a shift towards prevention in healthcare policy, as governments seek to contain spiraling treatment costs.There is a growing, if long overdue, recognition among policy-makers...

Conference Live for ongoing congress performance measurement

Director John Branston discusses the benefits of a mobile approach for evaluating medical conferences year-on-year